Infigratinib in Patients with Recurrent Gliomas and FGFR Alterations: A Multicenter Phase II StudyAndrew B. Lassman, Patrick Roth, Vinay K. Puduvalli et al.|Zurich Open Repository and Archive (University of Zurich)|2022Cited by 76
Supplementary Figure from Infigratinib in Patients with Recurrent Gliomas and <i>FGFR</i> Alterations: A Multicenter Phase II StudyAndrew B. Lassman, Patrick Roth, Juan Manuel Sepúlveda-Sánchez et al.|Unknown|2023Cited by 0